FF
CGEM icon

FourThought Financial’s Cullinan Oncology CGEM Stock Holding History

FourThought Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10K Hold
775
– – ﹤0.01% 1028
2022
Q2 		$10K Hold
775
– – ﹤0.01% 1017
2022
Q1 		$8K Hold
775
– – ﹤0.01% 1083
2021
Q4 		$12K Hold
775
– – ﹤0.01% 1039
2021
Q3 		$17K Buy
775
+74
+11% +$1.98K ﹤0.01% 983
2021
Q2 		$18K Buy
+701
New +$21.6K ﹤0.01% 966

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FourThought Financial's CGEM Position: Q3 2022 in Review

FourThought Financial held its Cullinan Oncology (CGEM) position steady in Q3 2022 at 775 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

FourThought Financial first reported a position in CGEM in Q2 2021 and has held it in 6 quarters since. The position peaked at $18K in Q2 2021. 99 funds tracked by Wall St. Rank hold CGEM as of Q3 2022.

  • FourThought Financial held 775 shares of Cullinan Oncology worth $10K as of Q3 2022.
  • FourThought Financial left its Cullinan Oncology share count unchanged in Q3 2022.
  • Cullinan Oncology made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1028 holding.
  • FourThought Financial first reported a position in Cullinan Oncology in Q2 2021 and has held it in 6 quarters since.
  • FourThought Financial's Cullinan Oncology position peaked at $18K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.